TVM Capital Life Science has invested $25 million in Lamab Biologics Inc., which is taking forward a new twist on an old story in tackling allergic conditions. The asset-centric virtual company is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback